title: Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety.
authors.forename: Jelena
authors.initials: J
authors.lastname: Ivanovic
authors.forename: Rita
authors.initials: R
authors.lastname: Bellagamba
authors.forename: Emanuele
authors.initials: E
authors.lastname: Nicastri
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Signore
authors.forename: Cristina
authors.initials: C
authors.lastname: Vallone
authors.forename: Massimo
authors.initials: M
authors.lastname: Tempestilli
authors.forename: Chiara
authors.initials: C
authors.lastname: Tommasi
authors.forename: Luisa
authors.initials: L
authors.lastname: Mazzitelli
authors.forename: Pasquale
authors.initials: P
authors.lastname: Narciso
mesh_terms: D000328:Adult; D018791:CD4 Lymphocyte Count; D000069454:Darunavir; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000378:metabolism / Q000821:virology; D019438:Ritonavir / Q000008:administration & dosage / Q000493:pharmacokinetics*; D013449:Sulfonamides / Q000008:administration & dosage / Q000493:pharmacokinetics*; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D019438:Ritonavir; D000069454:Darunavir